Zobrazeno 1 - 10
of 589
pro vyhledávání: '"Kuhara, H."'
Autor:
Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Matsumoto S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Honma K; Department of Diagnostic Pathology & Cytology, Osaka International Cancer Institute, Osaka, Japan., Maeda N; Department of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kimura T; Department of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan., Maniwa T; Department of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan., Okami J; Department of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Publikováno v:
Cancer medicine [Cancer Med] 2022 Jul; Vol. 11 (14), pp. 2744-2754. Date of Electronic Publication: 2022 Mar 10.
Autor:
Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Ohashi Y; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan., Okawa M; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan., Iida H; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan., Sonoda S; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan., Hiuge Y; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan., Hachimine M; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan., Yamamura A; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nakamoto N; Department of Emergency and Critical Care, Osaka General Medical Center, Osaka, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tanigami H; Department of Anesthesiology, Osaka International Cancer Institute, Osaka, Japan.
Publikováno v:
Oxford medical case reports [Oxf Med Case Reports] 2022 Jun 23; Vol. 2022 (6), pp. omac051. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022).
Autor:
Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Odani S; Cancer Control Center, Department of Oncology, Osaka International Cancer Institute, Osaka University Graduate School of Medicine, Japan., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, Japan., Miyake K; Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Japan.
Publikováno v:
Medicine [Medicine (Baltimore)] 2022 Apr 29; Vol. 101 (17), pp. e29076. Date of Electronic Publication: 2022 Apr 29.
Autor:
Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Publikováno v:
Thoracic cancer [Thorac Cancer] 2021 Dec; Vol. 12 (24), pp. 3426-3428. Date of Electronic Publication: 2021 Oct 25.
Autor:
Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Okami J; Department of General Thoracic Surgery, Osaka International Cancer Institute, Osaka, Japan., Takenaka S; Musculoskeletal Oncology Service, Osaka International Cancer Institute, Osaka, Japan., Honma K; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan., Kukita Y; Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan., Nagata S; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tahara H; Department of Cancer Drug Discovery and Development, Research Center, Osaka International Cancer Center, Osaka, Japan.; Project Division of Cancer Biomolecular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2021 Oct 06; Vol. 2 (11), pp. 100235. Date of Electronic Publication: 2021 Oct 06 (Print Publication: 2021).
Autor:
Kawachi H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kukita Y; Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan., Nakamura H; Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan., Honma K; Department of Diagnostic Pathology & Cytology, Osaka International Cancer Institute, Osaka, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Mizote Y; Department of Cancer Drug Discovery & Development, Osaka International Cancer Institute, Osaka, Japan., Akazawa T; Department of Cancer Drug Discovery & Development, Osaka International Cancer Institute, Osaka, Japan., Tahara H; Department of Cancer Drug Discovery & Development, Osaka International Cancer Institute, Osaka, Japan.; Project Division of Cancer Biomolecular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Publikováno v:
Immunotherapy [Immunotherapy] 2021 Jul; Vol. 13 (10), pp. 799-806. Date of Electronic Publication: 2021 May 25.
Autor:
Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan. Electronic address: kei.kunimasa@oici.jp., Oka T; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan., Hara S; Department of Respiratory Medicine, Itami City Hospital, Itami, Japan., Yamada N; Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan., Oizumi S; Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, Japan., Miyashita Y; Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Yamanashi, Japan., Kamada R; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan., Funamoto T; Department of Respiratory Medicine, Itami City Hospital, Itami, Japan., Kawachi H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kawamura T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Matsunaga T; Department of Medical Informatics, Osaka International Cancer Institute, Osaka, Japan., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Fujita M; Department of Onco-Cardiology, Osaka International Cancer Institute, Osaka, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 Mar; Vol. 153, pp. 186-192. Date of Electronic Publication: 2020 Nov 16.
Autor:
Tamiya M; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan. moto19781205@yahoo.co.jp., Kunimasa K; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan., Nishino K; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan., Matsumoto S; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6-5-1, Kashiwa City, Chiba, 277-8577, Japan., Kawachi H; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan., Kuno K; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan., Inoue T; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan., Kuhara H; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan., Imamura F; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwanoha 6-5-1, Kashiwa City, Chiba, 277-8577, Japan., Kumagai T; Department of Thoracic Oncology, Osaka Prefectural Hospital Organization, Osaka International Cancer Institute, Otemae 3-1-69, Chuo-ku, Osaka City, Osaka, 541-8567, Japan.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2021 Feb; Vol. 39 (1), pp. 232-236. Date of Electronic Publication: 2020 Jun 18.
Autor:
Morimoto M; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan morimoto-knk@umin.ac.jp., Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Wada K; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Konishi K; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan., Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Kimura M; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Hirata T; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Kanayama N; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan., Toratani M; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan., Kawachi H; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Ohira K; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Nakanishi E; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan., Ohira S; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan., Sagawa T; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan., Miyazaki M; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan., Matsunaga T; Department of Medical Informatics, Osaka International Cancer Institute, Osaka, Japan., Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Teshima T; Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.
Publikováno v:
Anticancer research [Anticancer Res] 2020 Dec; Vol. 40 (12), pp. 6957-6970. Date of Electronic Publication: 2020 Dec 07.
Autor:
Inoue, T., Kimura, M., Kunimasa, K., Tamiya, M., Kuhara, H., Nishino, K., Hino, T., Kumagai, T.
Publikováno v:
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S472-S472